PROVECTUS BIOPHARMACEUTICALS, INC. Accumulated Other Comprehensive Income
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) had Accumulated Other Comprehensive Income of -$59.80 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$59.80K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$59.91K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$60.19K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$60.33K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$59.80K 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$59.91K 10-Q · filed 2026-05-14 |
| 2025-12-31 | -$60.19K 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$60.33K 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$60.36K 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$60.69K 10-Q · filed 2025-05-14 |
| 2024-12-31 | -$60.74K 10-K · filed 2026-03-26 |
| 2024-09-30 | -$60.20K 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$60.45K 10-Q · filed 2024-08-13 |
| 2024-03-31 | -$60.58K 10-Q · filed 2024-05-14 |
| 2023-12-31 | -$60.16K 10-K · filed 2025-03-28 |
| 2023-09-30 | -$36.21K 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$35.77K 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$35.49K 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$35.68K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$36.75K 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$35.51K 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$35.18K 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$34.47K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$34.57K 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$34.38K 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$33.26K 10-Q · filed 2021-05-11 |
| 2020-12-31 | -$34.10K 10-K · filed 2022-03-29 |
| 2020-09-30 | -$32.45K 10-Q · filed 2020-11-12 |
| 2020-06-30 | -$30.80K 10-Q · filed 2020-08-12 |
| 2020-03-31 | -$33.03K 10-Q · filed 2020-05-13 |
| 2019-12-31 | -$24.01K 10-K · filed 2021-03-02 |
| 2019-09-30 | -$24.80K 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$24.86K 10-Q · filed 2019-08-08 |
| 2019-03-31 | -$22.36K 10-Q · filed 2019-05-13 |